docetaxel anhydrous has been researched along with vicenin ii in 2 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (vicenin ii) | Trials (vicenin ii) | Recent Studies (post-2010) (vicenin ii) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 68 | 0 | 46 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awasthi, S; Fast, S; Nagaprashantha, LD; Roby, R; Singhal, J; Singhal, SS; Vatsyayan, R | 1 |
| Awasthi, S; Horne, D; Jain, D; Singhal, J; Singhal, P; Singhal, SS | 1 |
1 review(s) available for docetaxel anhydrous and vicenin ii
| Article | Year |
|---|---|
Targeting the mercapturic acid pathway and vicenin-2 for prevention of prostate cancer.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apigenin; Docetaxel; Drug Resistance, Neoplasm; Glucosides; Humans; Male; Prostatic Neoplasms; Signal Transduction; Taxoids | 2017 |
1 other study(ies) available for docetaxel anhydrous and vicenin ii
| Article | Year |
|---|---|
Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Aorta; Apigenin; Apoptosis; Cell Line; Cell Movement; Docetaxel; Drug Synergism; Drug Therapy, Combination; Glucosides; Male; Mice; Mice, Nude; Neoplasms, Experimental; Prostatic Neoplasms; Taxoids; Time Factors; Tissue Culture Techniques | 2011 |